General Molecular Mechanisms and Functions of the Retinoid Receptor-Related Orphan Receptor Alpha (RORα) {#sec1-1}
========================================================================================================

The transcription factor, RORα belongs to the nuclear receptor family and is thought to act as a constitutive activator of transcription by binding to the ROR response element (RORE) of target genes. Through the ligand binding domain (LBD), co-activators and sterol-derived ligands (*i.e*., cholesterol, cholesterol metabolites and oxysterols) are able to modulate RORα activation. Binding to LBD leads to conformational changes of the LBD that facilitates the recruitment of transcriptional co-regulatory proteins (for review see Jetten, 2009; [**Figure 1**](#F1){ref-type="fig"}). However, more needs to be done to understand how RORα expression is precisely regulated. At the physiological level, RORα, on its own or in combination with other circadian related genes, participates in setting various physiological functions, for instance, in setting the circadian rhythm, in regulating metabolism, immunity and neuroprotection and appears as a key gene regulating some aspects of brain development and aging (Jetten, 2009; [**Figure 1**](#F1){ref-type="fig"}). At anatomical level RORα is widely expressed in various organs, including in specific regions of the central nervous system (Jetten, 2009). Here we will mainly focus on the roles of RORα in the development of the cerebellum and of the somatosensory system.

![Schematic representation of the molecular mechanism of retinoid receptor-related orphan receptor alpha (RORα) action, physiological functions and roles in diseases.\
The RORα is involved in the transcriptional activation of various target genes by binding to their ROR-response element (RORE) sequence. Its activation is regulated by the binding of sterol ligands and transcriptional co-activators to the LDB domain. AF1: Activation function 1; DBD: DNA-binding motif; LBD: ligand binding domain. RORα is critical in the regulation of many physiological processes and may have a role in several pathologies.](NRR-13-791-g001){#F1}

Roles of RORα in Cerebellar Development {#sec1-2}
=======================================

The staggerer mutation "characterized by the vacillating locomotion of the spontaneous mutant animal" was first identified by Richard Sidman during one of his visit to the Jackson laboratory in 1955. Staggerer mice were subsequently thoroughly analyzed with a focus on cerebellar development and motor functions. Subsequently, it was demonstrated that the staggerer mutation was a RORα deletion in the LDB that induced altered development, maturation, and maintenance of cerebellar Purkinje cells (PCs) and granular neurons resulting in the staggerer phenotype (*i.e*., Hamilton et al., 1996; reviewed in Jetten, 2009; the large array of work produced could not be acknowledged here due to space limitation). Recently, using elegant genetic models based on "cre-lox inducible strategy" allowing cell type- and time-specific ablation of RORα, the cell-autonomous functions of RORα in PCs development and maturation have been clarified (Takeo et al., 2015). RORα has been shown to be necessary for the neurogenesis of PCs (E10-13), for their migration to the cerebellar cortex (E15-17) and the alignment of their cell bodies. At postnatal stage, by P4, RORα was shown to promote the retraction of the few primitive dendrites of PCs that will then enter the "stellate cell" stage. By P8, RORα was shown to be necessary for PCs to retract their perisomatic dendrites and then to grow spiny branchelets. RORα expression is maintained throughout life in PCs and is necessary for survival of PCs, for the maintenance of cell morphology, and to ensure it is correctly innervated by a single climbing fiber (Chen et al., 2013). Alterations in cerebellar granular cells alterations appeared to be secondary to the failure of PCs to produce the morphogen, sonic hedgehog among other factors.

RORα is Cell-Autonomously Required for the Development of the Somatosensory System {#sec1-3}
==================================================================================

Despite region and time specific expression of RORα in various brain regions only few studies have analyzed the roles of RORα in brain circuit formation outside the cerebellum. Nakagawa and O'Leary were the first to report that RORα was expressed from E12.5 in sensory thalamic nuclei and from E18.5 in the cortical layer IV (Nakagawa and O'Leary, 2003). The development of the somatosensory system is sequential in time and place (for review see Lokmane and Garel, 2014). Whiskers on the snout of the mouse send inputs to the trigeminal ganglion cells that in turn project to the brainstem where these projections are topographically organized and represent the whisker map. The brainstem nucleus principalis (PrV) sends contralateral afferents to the ventrobasal thalamic nucleus (VB) where the topography is reproduced. In VB, each barreloid send thalamocortical axons (TCs) toward the center of a single barrel in the layer IV of the primary somatosensory cortex (S1), where TCs arborize. In the cortex, this organization is clearly visible from P4 onwards. In layer IV, a large proportion of glutamatergic neurons display asymmetric "stellate-like" morphologies with their soma located in the barrel walls and their dendrites preferentially oriented toward the barrel center forming synaptic contacts with TCs during the first postnatal weeks ([**Figure 2A**](#F2){ref-type="fig"}--[**A**](#F2){ref-type="fig"}').

![Schematic drawings showing the alterations found in the somatosensory system in various mouse models lacking retinoid receptor-related orphan receptor alpha (RORα) totally or partially.\
(A) In wild type mice, the nucleus principalis (PrV) sends direct axons (violet arrows) to the barreloids (green circles) in the ventrobasal thalamus nucleus (VB). In VB, barreloids replicate the topographical organization of the whiskers on the face of the animals. Each barreloid sends thalamocortical axons (TCs; green axons) to the layer IV of the primary somatosensory cortex (S1; black doted lines) and conveys the information from a single whisker. A barrel is constituted by spiny stellate neurons whose soma delineate the barrel walls (red curved line in S1 layer IV) and send their dendritic arborization toward the center of the barrel (not shown in A; see the preferential dendritic orientation in A') where TCs arborize profusely (green axons in S1 layer IV). (A') Drawings of a representative Golgi-Cox-labelled spiny stellate neuron (left) and of a representative DiI-labelled TC (right; triangles indicate the bottom of layer IV). (B--D) The blue color coding indicates the regions lacking RORα protein expression. (B) In staggerer mutant mice (sg/sg), VB (green area) and layer IV neurons (red dots) have lost their specific organization. In comparison with controls, specific genes are downregulated in staggerer VB (**i.e*., Netrin G1, CD47, CSPG5, NEPH*) and in staggerer cortex (**i.e*., SEMA7A, ADCY8, NEPH* and the transcription factor *NR2F1*). These genes are known to be implicated in barrel organization or neuritic outgrowth. (B') In staggerer mice, TCs are less complex (right) and layer IV neurons show less complex morphologies and have lost their specific orientation toward TCs (left). (C) Mice lacking RORα selectively in sensory thalamic nuclei (RORαTh) show altered TC segregation, although their general targeting in S1 is preserved. (C') TCs are less branched and less complex, leading to abnormal segregation and development of layer IV neurons. (D--D') In mice lacking RORα in cortical layer IV (RORαCtx), VB organization is preserved, but TCs axons are less complex and layer IV neurons are not segregated into barrels. (B--D) Note that in all these transgenic mice PrV organization is preserved (PrV afferents are shown in violet). *ADCY8*: Adenylate cylase Y8; CSPG5: chondroitin sulfate proteoglycan 5; *NEPH*: Neurofilament heavy molecular weight; *NR2F1*: nuclear receptor subfamily 2 group *F* member 1; *SEMA7A*: Semaphorin 7A.](NRR-13-791-g002){#F2}

In our recent study, we have analyzed the roles of RORα in the early postnatal development of the somatosensory system in staggerer mutant (sg/sg) mice but also in mice in which RORα was selectively deleted in the sensory thalamic nuclei or in the cortex (Vitalis et al., 2017). Staggerer mutant mice showed both a defective arborization of TCs and an altered organization of layer IV neurons into barrels, but a spared organization of the barrelettes in the brainstem ([**Figure 2B**](#F2){ref-type="fig"}--[**B**](#F2){ref-type="fig"}'). Whether these alterations are cell-autonomous or due to a combination of altered environmental and genetic signals remained to be clarified. To answer this question we performed genetic ablation of RORα in VB neurons from E15.5. Using the progeny of SERT:cre mice crossed with RORα floxed mice, we showed that RORα is cell-autonomously required for the growth and branching of TCs but not for their general topographical organization ([**Figure 2C**](#F2){ref-type="fig"}--[**C**](#F2){ref-type="fig"}'). Because the accurate topographical organization of TC neurons is necessary for normal layer IV organization, the roles of RORα on layer IV neurons could only be appreciated when specific ablation of RORα in layer IV neurons was achieved. Using the progeny of FoxG1:cre mice crossed with RORα floxed mice that ablates RORα from E18.5 in layer IV neurons, we showed that RORα is necessary for layer IV neurons to segregate into barrels and to display complex branched morphologies ([**Figure 2D**](#F2){ref-type="fig"}--[**D**](#F2){ref-type="fig"}'). To further confirm the cell autonomous requirement of RORα in TCs and barrels we obtained mutant mice lacking RORα in both the VB and the cortex. These animals, analyzed at early postnatal stage, recapitulated the cerebral features displayed by staggerer mice. This suggested that physiological/peripheral alterations known to occur in staggerer mice may contribute only minimally to the barrelless phenotype. However, we cannot exclude that a defect in neuroprotective functions mediated by RORα in astrocytes (Jolly et al., 2011) would exacerbate the "staggerer phenotype" at later stages. Indeed, it has been shown that downregulation of RORα induces an excessive upregulation of the pro-inflammatory cytokine IL6 and exerts an indirect repression of the nuclear factor kappa-B (NF-κB) pathway (Journiac et al., 2009).

The Lack of RORα in the Ventrobasal Thalamus and Somatosensory Cortex Induces the Downregulation of Key Genes Some of Which are Regulated by the Triiodothyronine (T3) {#sec1-4}
======================================================================================================================================================================

Our microarray analysis performed on the staggerer mice revealed that specific genes could be implicated in VB or layer IV staggerer phenotypes (see Lokmane and Garel, 2014; Vitalis et al., 2017) that review the role of some relevant molecules for barrel field development). Since RORα is considered to act as a positive activator of transcription, we focused our attention on genes downregulated in VB (131) and in S1 cortex (126) in staggerer mice. Among the genes potentially important for thalamic outgrowth we found *Netrin-G1 ligand*, the *CSG5* (chondroitin sulfate proteoglycan 5) and *CD47* (coding the transmembrane protein CD47) that were shown to promote the neuritogenesis and the maturation of cerebellar neurons. Similarly, several genes downregulated in the cortex and necessary for cortical development retained our attention: *Neph* and *Nepm* (coding neurofilament high and medium molecular weight), *Adenylate Cyclase 8*, the transcription factor *NR2F1* and *Semaphorin7A*. Downregulation of the neurofilaments protein H and Semaphorin 7A proteins were confirmed in staggerer mice. NEFM and NEFH are expressed in neuritic processes and participates in neuritic elongation and neuritic stability by phosphorylating cytoskeletal proteins including neurofilaments. The observed downregulation of heavy chain neurofilament in thalamic axons could induce a defective stability, or a delayed maturation of neurites. The lower expression of the GPI-linked Semaphorin 7A in staggerer mice could participate in the staggerer phenotype since its downregulation was shown to decrease the preferred orientation of spiny stellate neurons toward barrel centers and Semaphorin 7A is known to act as a positive signal for TCs outgrowth and branching (please, see our discussion in Vitalis et al., 2017).

Interestingly, several genes downregulated in the staggerer VB or cortex were previously shown to be regulated by T3 (Berbel et al., 2014; see also the work of the group of Beatriz Morte: *i.e*., Gil-Ibañez et al., 2017). Hypothyroid rats display characteristic features reminiscent to those displayed by staggerer mice: a preserved targeting of TCs toward S1 associated with defective axonal outgrowth and branching and a reduced layer IV cortical thickness (Berbel et al., 2014). Alteration in T3 signaling also induces cerebellar atrophy with a reduced growth and branching of PCs, among other cerebellar phenotypes, a feature partially overlapping with what was described in RORα deficient mice (Hamilton et al., 1996; Jetten, 2009; Chen et al., 2013; Takeo et al., 2015). *In vitro*, it was shown that T3 was one of the molecules able to positively regulate the activity of the RORα promoter and this regulation is lost in staggerer mice. This suggests that the defective T3/RORα pathway may account for some of the barrel field alterations we observed in staggerer mice. However, the complex interplay between T3/thyroid hormone receptors and RORα remains to be deciphered further. In addition, T3-independent pathways regulated by RORα and necessary for somatosensory system development remain to be clearly identified.

In our study, we were not able to detect significant modification of other circadian related genes and we believe that this may be due to technical limitations since these genes tend to regulate each other (see Jetten, 2009). In this respect, it needs to be mentioned that RORβ has been reported as a key regulator of barrel formation. RORβ is expressed at the same time and place than RORα (Nakagawa and O'Leary, 2003) and its early cortical upregulation (prior to the normal emergence of barrel formation) leads to anticipated layer IV clustering and to TC attraction in RORβ^+^ regions (Jabaudon et al., 2012). Interestingly, REV-ERBα that represses transcription through RORE (opposite function of RORα; Jetten, 2009) is also expressed in VB and in S1 (see the expression pattern at [www.alleninstitute.org](http://www.alleninstitute.org)) during the first postnatal week and might also play critical roles in somatosensory formation. Further investigations on the role of these circadian related genes on barrel formation will be of great value in the field.

Deregulation of RORα in Psychiatric Disorders {#sec1-5}
=============================================

The RORα gene is, as nicely shown by the work of Valerie Hu's group, at the crossroad of many biological processes and pathways which, when altered could lead to the emergence of various disorders (Sarachana and Hu, 2013). In human, polymorphism in the RORα gene has been associated with the susceptibility to develop several mental illnesses such as autistic-like syndrome (ASD), anxiety, depression and bipolar disorders. Several studies have shown that ASD patients displayed lower levels of RORα in the cerebellum and prefrontal cortex. In addition, in human and in mouse, RORα appears to be linked to the male bias of ASD since reduction of RORα regulates the aromatase enzyme and thus decrease RORα expression, downregulates androgens at the expense of oestrogens and can in turn influence circulating sex steroids (Sarachana and Hu, 2013). Following this work, other studies have shown that RORα expression, in males, was also associated with the emergence of anxiety following childhood maltreatment. In addition, the defective neuroprotection occurring when RORα is downregulated might exacerbate these pathologies (Journiac et al., 2009; Jolly et al., 2011). The data presented in this perspective strongly suggest a role for RORα in modeling and maintaining brain circuits and functions that could be affected in various psychiatric disorders.

Conclusion {#sec1-6}
==========

RORα, like other members of the circadian related genes, appears to play key roles in various physiological processes. RORα acts initially in various aspects of brain construction and later on in neuroprotection. Moreover, RORα, displays expression and regulation modified in various pathological conditions including psychiatric and degenerative disorders. Determining the appropriate amount of RORα activity could be crucial in detecting and preventing the emergence of specific diseases. Interestingly, natural or synthetic agonists, antagonists and inverse agonists are now available and could serve as potential diagnostic and therapeutic tools (Kojetin and Burris, 2014).
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